BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31439183)

  • 1. Oxidative stress, antioxidant status and lipid profile in pulmonary tuberculosis patients before and after anti-tubercular therapy.
    Vidhya R; Rathnakumar K; Balu V; Pugalendi KV
    Indian J Tuberc; 2019 Jul; 66(3):375-381. PubMed ID: 31439183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Sci Rep; 2019 Dec; 9(1):18217. PubMed ID: 31796883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    Miranda P; Gil-Santana L; Oliveira MG; Mesquita ED; Silva E; Rauwerdink A; Cobelens F; Oliveira MM; Andrade BB; Kritski A
    PLoS One; 2017; 12(4):e0175278. PubMed ID: 28384354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment.
    Omair M; Baig MS; Farooqui WA; Kousar S; Noori MY; Zeehan N; Khan A; Isa S; Kamran DS; Bari MF; Mehmood M
    BMC Infect Dis; 2024 Jun; 24(1):615. PubMed ID: 38907220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.
    Mesquita ED; Gil-Santana L; Ramalho D; Tonomura E; Silva EC; Oliveira MM; Andrade BB; Kritski A;
    BMC Infect Dis; 2016 Aug; 16():368. PubMed ID: 27494953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen.
    Agarwal A; Prasad R; Jain A
    Phytomedicine; 2010 Jan; 17(1):23-7. PubMed ID: 19910173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
    Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of some serum protein fractions as Early Index of Clinical Recovery in Pulmonary Tuberculosis subjects.
    Ukibe NR; Ndiuwem CK; Ogbu II; Ukibe SN; Ehiaghe FA; Ikimi CG
    Indian J Tuberc; 2020 Apr; 67(2):167-171. PubMed ID: 32553307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    Rahman SMM; Maliha UT; Ahmed S; Kabir S; Khatun R; Shah JA; Banu S
    PLoS One; 2018; 13(9):e0203063. PubMed ID: 30212505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with non-conversion of the direct smear after the initial phase of anti-tuberculous treatment. A study undertaken in three tuberculosis management centres in South Benin].
    Agodokpessi G; Wachinou AP; Awanou B; Gninafon M
    Rev Mal Respir; 2018 May; 35(5):546-551. PubMed ID: 29778620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.
    Yadav BK; Shah AK; Karunanand B; Sudan DS; Sharma M
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):33-37. PubMed ID: 36148507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.
    Singla R; Khan N; Al-Sharif N; Ai-Sayegh MO; Shaikh MA; Osman MM
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):74-9. PubMed ID: 16466041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Systemic Adipokine Levels in Pulmonary Tuberculosis and Changes following Treatment.
    Moideen K; Kumar NP; Nair D; Banurekha VV; Babu S
    Am J Trop Med Hyg; 2018 Oct; 99(4):875-880. PubMed ID: 30182920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Useful clues to the presence of smear-negative pulmonary tuberculosis in a West African city.
    Bah B; Massari V; Sow O; Siriwardana M; Camara LM; Larouzé B; Murray JF
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):592-8. PubMed ID: 12102298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases.
    Kim YK; Hahn S; Uh Y; Im DJ; Lim YL; Choi HK; Kim HY
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):725-9. PubMed ID: 24903945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.